# Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs

- Source: PR Newswire M&A
- Published: 2026-11-02T14:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/roche-receives-fda-510k-clearance-for-new-cobas-eplex-respiratory-pathogen-panel-3-enabling-labs-to-customize-respiratory-testing-for-local-patient-needs-302926499.html
- Canonical: https://groundlevelnews.com/story/roche-receives-fda-510-k-clearance-for-new-cobas-eplex-respiratory-pat-193f7c/

The new cobas® eplex RP3 panel detects up to 19 viruses and bacteria, with newly added Bordetella pertussis and improved inclusivity of influenza A and SARS-CoV-2 strains, from a single sample to inform timely patient management. Laboratories can optimize resources with up to five...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._